The CLIA Molecular Diagnostics Laboratory makes clinical Sanger sequencing, genetic mutation detection, and gene expression technologies available to researchers.
We strive to support cancer and other disease-related research by providing access to cutting-edge technologies and specialized services, including nucleic acid extraction, fragment analysis, droplet digital polymerase chain reaction, next-generation sequencing, and NanoString analysis.
The laboratory works with groups within the National Institutes of Health, as well as academic partners. Potential collaborators can contact us to inquire about accessing our services.
Clinical laboratories must be CLIA (Clinical Laboratory Improvement Amendments) certified by the state and the Center for Medicare and Medicaid Services to accept human samples for diagnostic testing.
We have been CLIA certified for more than 20 years.